Key facts
- It has raised $2.0M; the latest was Early Stage VC ($6.0M) in May 2025.
- Notable investors include Conscious Venture Partners, DNAthlete.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Maxiom Labs
- ·The full record, as it builds
Funding rounds
No funding rounds for Maxiom Labs are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Maxiom Labs
Developer of an artificial intelligence-driven meta-analyses platform intended to optimize health, fitness, and performance for committed athletes and everyday achievers. The company's platform analyzes workouts, workout data, and biometrics to create custom workout and meal plans that align with preferences, biology, and goals, delivering information to continually refine training and recovery, enabling users to access customized sports nutrition, achieve peak performance and lifelong health.
- Sector
- Healthcare
- HQ
- Palo Alto, CA, United States
- Founded
- 2023
- Employees
- 6
- Website
- maxiom.io/
- Ownership
- Privately Held (backing)
Maxiom Labs doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Maxiom Labs shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Maxiom Labs in its N-PORT filings yet. We sweep new filings monthly.